What is the status of the Clinical Trial?

The Phase 1 trial is currently underway at three trial sites in the Maryland/DC metropolitan area. It will take until mid-2021 (possibly a little longer) to get the first data from the Phase 1 study. The first trial participant has already been enrolled, so the next big milestone is the first infusion, which should occur by April 2021.  Safety data may be available as early as one month after the first infusion.